Clinical Trials Browser

Phase 2 × pidilizumab × Plasma cell × Clear all

NCT01067287 2025-01-24

Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation

Phase 2 Active not recruiting

Multiple Myeloma